Table 3.
Impact inventory and cost analysis of CVD-related model outputs for individuals aged 30 to 79 years, assessed cumulatively over the 20-year simulation period from 2013 to 2032 (US$ millions, except when percentages). Brackets contain 95% uncertainty intervals
| Outcome | Men | Women | Persons | As percentage of total costs |
|---|---|---|---|---|
| Change in total health-related costs | 190 (48 to 440) | 100 (23 to 250) | 290 (71 to 690) | 0.094% (0.055 to 0.17%) |
| Total medical costs to SUS | 140 (36 to 330) | 78 (17 to 190) | 220 (54 to 530) | As above |
| Total informal care costs | 46 (12 to 110) | 25 (6 to 61) | 71 (17 to 170) | As above |
| Total CHD-related costs | 150 (38 to 350) | 70 (14 to 180) | 220 (52 to 530) | 0.072% (0.030 to 0.15%) |
| CHD medical costs to SUS | 120 (29 to 270) | 54 (11 to 130) | 170 (40 to 400) | As above |
| Informal care CHD costs | 36 (9 to 84) | 17 (3 to 42) | 52 (12 to 130) | As above |
| Total stroke-related costs | 38 (10 to 86) | 33 (9 to 76) | 72 (19 to 160) | 0.14% (0.068 to 0.23%) |
| Stroke medical costs to SUS | 28 (7 to 64) | 25 (7 to 56) | 53 (14 to 120) | As above |
| Informal care stroke costs | 10 (3 to 22) | 9 (2 to 20) | 19 (5 to 42) | As above |